Metofoli 500 Infusion contains Metronidazole 500mg, a trusted intravenous antibacterial and antiprotozoal agent widely used in hospital and critical care settings. It is indicated for the management of serious anaerobic bacterial infections, protozoal infections, intra-abdominal infections, septicemia, and surgical prophylaxis.
Metronidazole works by penetrating microbial cells and inhibiting nucleic acid synthesis, leading to rapid cell death of susceptible anaerobic bacteria and protozoa. Its intravenous administration ensures rapid systemic availability, making it ideal for moderate to severe infections requiring immediate intervention.
For distributors and healthcare suppliers, Metofoli 500 Infusion is a high-rotation hospital anti-infective product, routinely used in general surgery, gynecology, gastroenterology, and intensive care units. Continuous hospital demand and protocol-based usage ensure consistent consumption.
Adding Metofoli 500 Infusion to your injectable antibacterial and antiprotozoal therapy segment opens strong opportunities in hospital supply chains, nursing homes, emergency care units, export markets, and third-party manufacturing. Its broad clinical acceptance, critical therapeutic role, and dependable efficacy make it a key product in pharmaceutical distribution portfolios.